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Abstract
Background. Portal vein thrombosis (PVT) is a well recognized complication of patients with end-stage cirrhosis and its
incidence ranges from 2 to 26%. The aim of this study was to analyze the results and long-term follow-up of a consecutive
series of liver transplants performed in patients with PVT and compare them with patients transplanted without PVT.
Patients and methods. Between July 1995 and June 2006, 26 liver transplants were performed in patients with PVT (8.7%).
Risk factors and variables associated with the transplant and the post-transplant period were analyzed. A comparative
analysis with 273 patients transplanted without PVT was performed. Results. The patients comprised 53.8% males, average
age 40, 7 years. PVT was detected during surgery in 65%. Indications for transplantation were: post-necrotic cirrhosis 73%,
cholestatic liver diseases 23%, and congenital liver fibrosis 4%. Child-Pugh C: 61.5%. Techniques were trombectomy in 21
patients with PVT grades I, II, IV, and extra-anatomical mesenteric graft in 5 with grade III. Morbidity was 57.7%,
recurrence of PVT was 7.7%, and in-hospital mortality was 26.9%. Greater operative time, transfusion requirements, and
re-operations were found in PVT patients. One-year survival was 59.6%: 75.2% for grade 1 and 44.8% for grades 2, 3, and
4. Discussion. The study demonstrated a PVT prevalence of 8.7%, a higher incidence of partial thrombosis (grade 1), and
successful management of PVT grade 4 with thrombectomy. Liver transplant in PVT patients was associated with an
increased operative time, transfusion requirements, re-interventions, and lower survival rate according to PVT extension.
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Introduction
Portal vein thrombosis (PVT) is a well recognized
complication of patients with end-stage cirrhosis and
its incidence ranges from 2 to 26% in different series
[1]. The etiology, not yet fully understood, is based on
the thrombotic tendency related to several factors:
altered liver anatomy that increases the intrahepatic
resistance to portal flow, endothelial injury due to an
elevated portal pressure, and coagulation abnormal-
ities [2,3]. Considered for two decades an absolute
contraindication for liver transplantation (LTx), in
1985 the first report of a successful transplantation
in two patients with PVT was published [4]. Advances
in the intraoperative management of this entity and
encouraging results produced an increase in the
number of transplants performed with PVT that at
the present time is from 2 to 19% [5]. Although
screening of the portal vein (PV) patency is routinely
performed in the preoperative evaluation of candi-
dates, unsuspected PVT continues to be found
intraoperatively. Nowadays, the procedure is per-
formed even in cases of extended thrombosis with
inflammatory changes of the portal vein axis [2].
However, PVT continues to be associated with a
considerable perioperative risk for LTx candidates.
Patients and methods
Records of patients transplanted at the Liver Trans-
plant Unit of the Hospital Dr Cosme Argerich,
Buenos Aires, Argentina were retrospectively re-
viewed. From July 2005 to June 2006, 323 LTx
were performed and 26 patients with intraoperatively
confirmed PVT were included in the study (8.7%).
Patients with tumor thrombus of the PV were
excluded. Based on intraoperative assessment, PVT
was retrospectively classified according to Yerdel et al.
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into four grades, as follows. Grade 1: partial PVT
(B 50% of the lumen) with or without minimal
extension into the superior mesenteric vein (SMV).
Grade 2:50% occlusion with or without minimal
extension into the SMV. Grade 3: complete throm-
bosis of both PV and proximal SMV. Distal SMV is
open. Grade 4: complete thrombosis of the PV and
proximal and distal SMV.
The preoperative study of the candidates for LTx
consisted of systematic Doppler sonography. In cases
where suspicion of PVT was high, conventional
angiography or spiral CT arterial portography were
performed.
Risk factors analyzed for PVT were as follows: age,
sex, etiology, Child-Pugh classification, previous
treatments for portal hypertension (sclerotherapy,
shunt surgery, transjugular intrahepatic portosystemic
shunt  TIPS), and previous upper abdominal
surgery.
Orthotopic liver transplantation was performed
using whole cadaveric grafts with classic venovenous
bypass technique in 17 patients and piggy-back in 9
patients. The PV was dissected entirely to determine
the extent of the thrombus and, in selected cases with
distal extension, inframesocolonic SMV was also
dissected.
Follow-up consisted of Doppler ultrasound on the
first, third, fifth, and seventh postoperative day, and
the first and third month, and then every time it was
considered clinically necessary.
Intraoperative and postoperative variables analyzed
were: surgical technique according to PVT grade,
cold ischemia time, anhepatic phase and whole
transplant duration, blood requirements, re-interven-
tions, recurrence of PVT, early and late postoperative
deaths, and survival.
A comparative analysis was performed with 273
patients without PVT transplanted in the same
period.
Statistical analysis
Qualitative variables expressed as frequencies and
percentages were compared using the x2 test. For
quantitative variables expressed as mean values and
standard deviation comparison was done applying the
Student’s t test. The KaplanMeier method was used
to calculate actuarial survival rates and inter-group
comparisons were performed by means of the log-rank
test. Statistical significance was considered to exist
when pB0.05. Statistical analyses were performed
using SPSS v12.0.
Results
Among 26 patients with PVT, 14 were males and 12
were females with a median age of 40 years (range
1761). PVT was diagnosed preoperatively in 9
patients (35%) and during the transplant procedure
in 17 (65%). Indications for LTx were predominantly
related to post-necrotic cirrhosis in 73% (19/26) of
the cases (alcoholic 6, cryptogenic 5, post-hepatitis C
5, post-hepatitis B 2, autoimmune 1), cholestatic liver
diseases in 23% (6/26) (primary sclerosing cholangitis
(PSC) 4, primary biliary cirrhosis 2), and congenital
hepatic fibrosis in 4% (1/26). Child-Pugh class C was
present in 61.5%. Before transplantation 53.8%
(14/26) had undergone sclerotherapy, 7.6% (2/26)
TIPS, and 42.3% (11/26) upper abdominal surgery
with cholecystectomy as the most common procedure
(63%). There was no previous portosystemic shunt.
Of the 26 patients with PVT, 13 had grade 1 (50%), 5
grade 2 (19%), 5 grade 3 (19%), and 3 grade 4
(12%). Operative management consisted of throm-
bectomy with or without endovenectomy in 21
patients with PVT grades 1, 2, and 4, and venous
jump graft from the superior mesenteric vein in 5
patients with PVT grade 3 [6]. Fifteen (57%) patients
received preventive anticoagulant therapy with low
molecular weight heparin followed by aspirin for 6
months. The average complication rate in patients
with PVT was 57.7%  infectious complications in
46.2% (5/12), and reoperations in 39%. The overall
incidence of PV rethrombosis was 7.7% (two pa-
tients). The first was transplanted for congenital
hepatic fibrosis, and at the 16th postoperative day
presented left PV thrombosis and required a left
hepatectomy. At the 23rd day a second rethrombosis
recurred in the main portal trunk and right branch,
the patient was included in the waiting list for
retransplantation but died due to multi-organ failure.
The second death corresponds to a patient who
presented a simultaneous arterial thrombosis, PV
rethrombosis, and graft failure in the early post-
transplantation period. Five patients (two PVT grade
1, two PVT grade 2, and one PVT grade 3) required
retransplantation. In-hospital mortality and late mor-
tality were 26.9% and 19.2%, respectively (Table I).
The overall actuarial 1-year survival rate in PVT
patients (59%) was lower than in non-PVT patients
(80.5%, pB0.001) (Figure 1). According to PVT
classification, patients with grade 1 demonstrated a
trend towards better 1- and 5-year survival rates
than grades 2, 3, and 4 (75.2% vs 44.8%; p0.4)
(Figure 2) Two of the three patients with PVT grade
IV treated by thrombectomy were alive at 68 and 128
months post-transplant, respectively.
A comparative analysis performed with 273 patients
transplanted without PVT also showed significance in
the following variables: previous surgery, transfusion
requirements, reoperations, and portal rethrombosis
(Table II).
Discussion
The incidence of PVT in our series was 8.7%, similar
to the results reported by most liver transplant centers
since the 1990s, which range from 2 to 16% [7].
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Although different etiologies of liver failure have been
associated with PVT, our data showed a significant
association with post-necrotic cirrhosis (73%), espe-
cially with Laennec’s, hepatitis C virus (VHC), and
cryptogenic cirrhosis [8]. Unlike others, a higher rate
of PVT was found in PSC (15%) [7,8].
Several risk factors for PVT, such as male gender,
Child-Pugh C, previous treatments for portal hyper-
tension (sclerotherapy, TIPS, shunt surgery, splenect-
omy), and previous surgical interventions were
described [9,10]. The predominance in males is likely
to be related to the higher incidence of Laennec’s
cirrhosis in this population [9,11]. Treatments for
bleeding indicate a more pronounced portal hyper-
tension that justifies the higher incidence of PVT due
to the hemodynamic changes in the PV (low or
reversed flow) [10]. In our study 54% of the patients
with PVT had been treated by sclerotherapy.
It is standard practice in the pre-LTx evaluation to
perform Duplex ultrasonography (US) of the hepatic
vasculature. Accuracy in detecting PVT ranges from
26% to 87%. This is explained by a high incidence of
false negatives due to the extension of PVT, the
identification of portal collaterals as the PV, and the
post-US thrombosis of the PV while patients
are awaiting transplantation [12,13]. Other radiologi-
cal methods include angiography, angio-MRI, and
less often spiral CT arterial portography [2,9,12].
Despite exhaustive radiological evaluation before
LTx, cases of undiagnosed PVT continue to be found
during surgery. In our series this (65%) could be
justified by the high incidence of PVT grade 1 [14].
Several PVT classifications have been proposed
[6,9,10,14]. We consider Yerdel’s the most adequate
because it correlates the thrombosis extension with
the surgical technique and outcome [9].
An adequate portal inflow to the graft is essential
for good liver function. Different approaches have
been proposed to restore PV patency at the time of
OLT, such as thrombectomy, the use of venous
interposition grafts, the use of PV collaterals, and
cavoportal hemitransposition [6,15]. In grades 1 and
2 with totally patent SMV, thrombectomy is the
procedure of choice [5,13,16]. The intraoperative
Table I. Causes of mortality in patients with PVT who underwent liver transplantation.
Period Cause n Survival
Early Post-reperfusion cardiac arrest (T) 1 Day 0
Primary non-function (JG) 2 Day 1
Rethrombosisarterial thrombosis (JG) 1 Day 1
MOF (sepsis) (T) 1 Day 1
Pontine myelinolysis (T) 1 Day 49
Rethrombosissepsis (T) 1 Day 52
Late Sepsis (T) 1 2 months
Arterial thrombosis (2nd day after re-transplantation) (T) 1 2 months
Chronic rejection (T) 1 11 months
VHC recurrence (T) 1 69 months
Pneumopathy (T) 1 88 months
Intraoperative management of PVT: T, thrombectomy; JG, venous jump graft from SMV.
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Figure 1. Overall patient survival rates in patients with and without
PVT.
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Figure 2. Overall survival in patients with grade 1 PVT and
combined grades 24 PVT.
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strategy should be to determine first the extent of the
thrombosis with proximal dissection of the PV and
progressive separation of the thrombus from the
surrounding vessel wall by the eversion technique.
Also, as thrombi are usually organized, Fogarty
catheter thrombectomy is not amenable [13]. In
patients with proximally occluded but distally open
SMV (grade 3), we prefer the extra-anatomic jump
graft with donor iliac vein [9,17]. It is tunneled
through the transverse mesocolon, anterior to the
pancreas and posterior to the pylorus, avoiding
extensive peripancreatic dissection of the anatomic
graft with its attendant morbidity [13,16]. If the
thrombosis extends to the distal SMV (grade 4),
different procedures have been described to restore
portal inflow: anastomosis of the donor PV to the
recipient left gastric vein or a suitable tributary, jump
graft to a recanalized SMV, PV arterialization, throm-
bectomy, cavoportal hemitransposition, and com-
bined liverintestine transplantation [6,9,13].
Stieber et al. were the first to report successful
outcome in patients with extensive PVT after throm-
bectomy [6]. In contrast to a previous study, two-
thirds of patients with PVT grade 4 treated by this
method are still alive with normal graft function at 5
years [9]. As Tzakis et al. reported, cavoportal
hemitransposition has been proposed as a means of
overcoming the problem of extensive PV thrombosis
[15]. However, the most common complications of
this procedure are severe ascites and variceal bleeding
due to the persistent portal hypertension [18]. Better
patient selection and the use of the renoportal
hemitransposition have demonstrated long-term sur-
vival [18,19]. Recently, endovascular techniques dur-
ing LTx have shown their value in solving some liver
graft perfusion problems in patients with PVT grades
3 or 4 [20,21].
The greater technical difficulty in patients with pre-
existing PVT has demonstrated an increased risk of
complications like hepatic artery thrombosis, relapar-
otomy, postoperative pancreatitis, sepsis, and renal
failure in different studies [9,12,16]. Operative time
and anhepatic phase could be longer and transfusion
requirements higher, as was observed in this study
[7,13,16]. A higher incidence of primary nonfunction
or dysfunction could be related to more complex
surgical procedures in fragile patients with severe
portal hypertension [9]. Despite surgical progress,
the perioperative mortality rates of LTx in the
presence of PVT remains high, ranging from 9 to
42% [12].
Rethrombosis of the PV in this series occurred in
only 7.7% of our PVT patients, which compares
favorably with the published rates from 6.2% to
28.6% [2,13,14]. It carries a poor prognosis, and
mortality of rethrombosis in our series was 100%.
However, there are no uniform criteria for the use of
prophylactic measures. Some advocate preventive
regimens with low molecular weight heparin, dextran,
coumadin derivatives, or aspirin, while others only use
systemic anticoagulation in patients with hypercoa-
gulable states [8,9,12,13].
In general, 1-year survival after LTx in patients with
PVT ranges from 59% to 88%, and has a close
relationship to the PVT extension [5]. In this study
the overall 1-year survival in PVT patients (59%) was
lower than in non-PVT patients (80.5%). It is
interesting that 1-year and 5-year survival in PVT
patients was identical, reflecting that once they have
survived the peri-transplant period, the outcome is
identical to non-PVT patients. According to the
severity of PVT we found a trend toward a difference
in survival between grade 1 (75%) vs grades 2, 3, and
4 (45%), but this was not statistically significant.
Experience in the management of PVT has demon-
strated that patients with minimally thrombosed PV
(grade 1), can undergo successful transplantation with
similar results to non-PVT patients [8,9,13].
In conclusion, we confirm that PVT is not a
contraindication to LTx at the present time. Our
study demonstrated a PVT prevalence of 8.7%, and a
higher incidence of partial thrombosis (grade 1) that
explains the elevated rate of intraoperative diagnosis.
LTx in PVT patients was associated with an increase
Table II. Comparative analysis of liver transplantation in patients with and without PVT.
Parameter With PVT (n26) Without PVT (n273) p value
Age (years) 41.9 40.3 0.4
Sex (%)
Male 53.8 43.5 0.3
Female 46.2 56.5
Previous surgery (%) 42.31 24.1 0.03
Cold ischemia time (min) 543.04 523.4 0.6
Operative time (h) 8.65 7.8 0.3
Anhepatic phase (min) 66.04 57.23 0.08
RBC (u) 14.52 10.14 0.03
Plasma (u) 13.08 12.65 0.1
Platelets (u) 6.24 5.28 0.02
Reoperations (%) 39 24.7 0.03
Rethrombosis 2/26 2/273 0.001
1-year survival (%) 59.60 80.5 0.0003
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of the operative time, the transfusion requirements,
the incidence of re-interventions, and a lower survival
rate according to PVT extension. In PVT grade 4,
successful management with thrombectomy avoided
the utilization of other proposed techniques.
Acknowledgements and disclosures
No disclosures.
References
[1] Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V,
Condat B, et al. Splanchnic vein thrombosis in candidates for
liver transplantation: usefulness of screening and anticoagula-
tion. Gut 2005;/54:/6917.
[2] Orlando G, De LL, Toti L, Zazza S, Angelico M, Casciani
CU, et al. Liver transplantation in the presence of portal vein
thrombosis: report from a single center. Transplant Proc 2004;/
36:/199202.
[3] Bayraktar Y, Harmanci O. Etiology and consequences of
thrombosis in abdominal vessels. World J Gastroenterol
2006;/12:/116574.
[4] Shaw BW Jr, Iwatsuki S, Bron K, Starzl TE. Portal vein grafts
in hepatic transplantation. Surg Gynecol Obstet 1985;/161:/
668.
[5] Robles R, Fernandez JA, Hernandez Q, Marin C, Ramirez P,
Sanchez-Bueno F, et al. Eversion thromboendovenectomy in
organized portal vein thrombosis during liver transplantation.
Clin Transplant 2004;/18:/7984.
[6] Stieber AC, Zetti G, Todo S, Tzakis AG, Fung JJ, Marino I,
et al. The spectrum of portal vein thrombosis in liver
transplantation. Ann Surg 1991;/213:/199206.
[7] Gimeno FA, Calvo J, Loinaz C, Meneu JC, Perez B, Gomez R,
et al. Comparative analysis of the results of orthotopic liver
transplantation in patients with and without portal vein
thrombosis. Transplant Proc 2005;/37:/3899903.
[8] Molmenti EP, Roodhouse TW, Molmenti H, Jaiswal K, Jung
G, Marubashi S, et al. Thrombendvenectomy for organized
portal vein thrombosis at the time of liver transplantation. Ann
Surg 2002;/235:/2926.
[9] Yerdel MA, Gunson B, Mirza D, Karayalcin K, Olliff S,
Buckels J, et al. Portal vein thrombosis in adults undergoing
liver transplantation: risk factors, screening, management, and
outcome. Transplantation 2000;/69:/187381.
[10] Gayowski TJ, Marino IR, Doyle HR, Echeverri L, Mieles L,
Todo S, et al. A high incidence of native portal vein
thrombosis in veterans undergoing liver transplantation.
J Surg Res 1996;/60:/3338.
[11] Loinaz C, Gomez R, Jimenez C, Gonzalez-Pinto I, Garcia I,
Gimeno A, et al. Liver transplantation in patients with portal
thrombosis: results in 76 patients. Transplant Proc 2002;/34:/
2489.
[12] Dumortier J, Czyglik O, Poncet G, Blanchet MC, Boucaud C,
Henry L, et al. Eversion thrombectomy for portal vein
thrombosis during liver transplantation. Am J Transplant
2002;/2:/9348.
[13] Seu P, Shackleton CR, Shaked A, Imagawa DK, Olthoff KM,
Rudich SR, et al. Improved results of liver transplantation in
patients with portal vein thrombosis. Arch Surg 1996;/131:/
8404.
[14] Charco R, Fuster J, Fondevila C, Ferrer J, Mans E, Garcia-
Valdecasas JC. Portal vein thrombosis in liver transplantation.
Transplant Proc 2005;/37:/39045.
[15] Tzakis AG, Kirkegaard P, Pinna AD, Jovine E, Misiakos EP,
Maziotti A, et al. Liver transplantation with cavoportal
hemitransposition in the presence of diffuse portal vein
thrombosis. Transplantation 1998;/65:/61924.
[16] Bertelli R, Nardo B, Montalti R, Beltempo P, Puviani L,
Cavallari A. Liver transplantation in recipients with portal vein
thrombosis: experience of a single transplant center. Trans-
plant Proc 2005;/37:/111921.
[17] Lerut JP, Mazza D, van Leeuw V, Laterre PF, Donataccio M,
de Ville de Goyet J, et al. Adult liver transplantation and
abnormalities of splanchnic veins: experience in 53 patients.
Transpl Int 1997;/10:/12532.
[18] Ceulemans B, Aerts R, Monbaliu D, Coosemans W, Verslype
C, Van SW, et al. Liver transplantation using cavoportal
transposition: an effective treatment in patients with complete
splanchnic venous thrombosis. Transplant Proc 2005;/37:/
11124.
[19] Azoulay D, Adam R, Castaing D, Muresan S, Essomba A,
Vibert E, et al. [Liver transplantation with cavoportal or
renoportal anastomosis: a solution in cases of diffuse portal
thrombosis.] Gastroenterol Clin Biol 2002;26:32530 (in
French).
[20] Marini M, Gomez-Gutierrez M, Cao I, Selles C, Aguirreza-
balaga J, Otero A, et al. Endovascular treatment of splenome-
senteric-portal vein thromboses during orthotopic liver
transplantation. J Vasc Interv Radiol 2005;/16:/113542.
[21] Gomez-Gutierrez M, Quintela J, Marini M, Gala B, Suarez F,
Cao I, et al. Portal vein thrombosis in patients undergoing
orthotopic liver transplantation: intraoperative endovascular
radiological procedures. Transplant Proc 2005;/37:/39068.
356 J. Lendoire et al.
